Australia, Jan. 21 -- Purdue Pharma L.P, owns the trademark (2470105) for 'ZURNAI' till July 30, 2034.
Status: registered:
Registered/protected
Class: 5 [Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists.]
Type of Mark: Word
Date of Acceptance: July 31, 2024
Registration Advertised: Jan. 20
For further details contact AJ Park.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2470105.
Disclaimer: Curated by HT Syndication.
